chr11-47238177-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_000107.3(DDB2):c.1228G>A(p.Ala410Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,610,774 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000107.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDB2 | NM_000107.3 | c.1228G>A | p.Ala410Thr | missense_variant | 9/10 | ENST00000256996.9 | NP_000098.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDB2 | ENST00000256996.9 | c.1228G>A | p.Ala410Thr | missense_variant | 9/10 | 1 | NM_000107.3 | ENSP00000256996 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00253 AC: 385AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00255 AC: 624AN: 244966Hom.: 2 AF XY: 0.00233 AC XY: 308AN XY: 132272
GnomAD4 exome AF: 0.00378 AC: 5520AN: 1458466Hom.: 19 Cov.: 33 AF XY: 0.00368 AC XY: 2668AN XY: 725198
GnomAD4 genome AF: 0.00253 AC: 385AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.00240 AC XY: 179AN XY: 74486
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | DDB2: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 24, 2020 | This variant is associated with the following publications: (PMID: 24728327) - |
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The DDB2 p.Ala410Thr variant was not identified in the literature nor was it identified in LOVD 3.0 or Cosmic. The variant was identified in dbSNP (ID: rs143049891) and ClinVar (classified as likely benign by Invitae). The variant was identified in control databases in 690 of 276356 chromosomes (2 homozygous) at a frequency of 0.002497 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 526 of 126090 chromosomes (freq: 0.004172), European (Finnish) in 52 of 24444 chromosomes (freq: 0.002127), Other in 14 of 7086 chromosomes (freq: 0.001976), Latino in 66 of 34698 chromosomes (freq: 0.001902), African in 27 of 24524 chromosomes (freq: 0.001101) and South Asian in 5 of 29572 chromosomes (freq: 0.000169), but was not observed in the Ashkenazi Jewish, or East Asian populations. The p.Ala410 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 07, 2023 | - - |
Xeroderma pigmentosum, group E Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Xeroderma pigmentosum Benign:1
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Mar 12, 2021 | - - |
DDB2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 16, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at